9 Meters Biopharma Inc
(NMTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,436 | 13,474 | 2,668 | 4,593 | 8,864 |
| Other current assets | 75 | 75 | 75 | 75 | 75 |
| TOTAL | $13,633 | $14,610 | $3,231 | $5,223 | $9,720 |
| Non-Current Assets | |||||
| PPE Net | 45 | 52 | 20 | 25 | 29 |
| Other Non-Current Assets | 232 | 20 | 35 | 48 | 62 |
| TOTAL | $277 | $72 | $55 | $74 | $90 |
| Total Assets | $13,910 | $14,682 | $3,286 | $5,297 | $9,810 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,565 | 3,448 | 5,076 | 3,890 | 3,057 |
| Accrued Expenses | 6,067 | 3,284 | 4,848 | 4,748 | 1,863 |
| Other current liabilities | 161 | 247 | 1,499 | 3,046 | 3,958 |
| TOTAL | $10,108 | $11,615 | $15,836 | $14,911 | $13,125 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 181 | 0 | 0 | 0 | 0 |
| TOTAL | $181 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $10,289 | $11,615 | $15,836 | $14,911 | $13,125 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,516 | 6,947 | 4,813 | 2,066 | 1,794 |
| Common Shares | 15 | 14 | 4 | 4 | 4 |
| Retained earnings | -127,099 | -118,765 | -74,168 | -70,565 | -61,660 |
| TOTAL | $3,621 | $3,067 | $-12,550 | $-9,614 | $-3,315 |
| Total Liabilities And Equity | $13,910 | $14,682 | $3,286 | $5,297 | $9,810 |